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Metabolic reprogramming has emerged as an important feature of immune cell activation. Two new studies,
including Sena et al. (2013) in this issue of Immunity, identify mitochondrial reactive oxygen species (ROS)
arising from metabolic reprogramming as signaling molecules in T cell activation.Rather than just being a metabolic ‘‘waste
product’’ that can damage cellular com-
ponents through oxidation, reactive
oxygen species (ROS) can modify signal
transduction and metabolism through
reversible oxidative modification of
cellular target proteins (Finkel, 2012;
Sena and Chandel, 2012). Excess mito-
chondrial ROS are most likely generated
as a result of the profound metabolic
changes that occur during immune cell
activation (Jones and Thompson, 2007).
Resting lymphocytes and monocytes
exist in a terminally differentiated state
requiring little energy and relying on
oxidative phosphorylation to efficiently
generate ATP for basal metabolic
processes. Cell enlargement, followed
by cell division in the case of lympho-
cytes, creates a large demand for biosyn-
thesis of proteins, lipids, and DNA.
Immune cells meet these biosynthetic
challenges by shifting towardmacromole-
cule-generating metabolic pathways,
such as the generation of nucleotides
through glycolysis and the pentose-
phosphate shunt, and synthesis of amino
acids and lipids from intermediates in the
tricarboxylic acid (TCA) cycle.
Mitochondria, which house the
enzymes that carry out the TCA cycle
and cellular respiration, are central to
these metabolic adaptations. In T cells,
T cell receptor (TCR) signaling leads to
the release of stored Ca2+ from the endo-
plasmic reticulum; this Ca2+ is taken up
by mitochondria and stimulates many
of the enzymes in the TCA cycle, result-
ing in increased production of NADH
and anabolic TCA-cycle intermediates.
NADH and succinate fuel the mitochon-
drial electron transport chain (ETC),
leading to increased oxygen consumption
and mitochondrial membrane potential.Although most of the electrons flowing
through the respiratory chain are ulti-
mately transferred to oxygen at complex
IV, some electrons ‘‘leak’’ from ETC
enzyme complexes, particularly com-
plexes I and III, and react with molecular
oxygen to produce superoxide (O2
,-).
Mitochondrial superoxide is largely
converted to hydrogen peroxide (H2O2)
by Mn-superoxide dismutase (MnSOD)
(Murphy, 2009). Because H2O2 can
permeate membranes, it is likely that this
is the major redox signal emanating from
mitochondria. H2O2 can reversibly oxidize
protein thiols by introducing alterations
such as sulfenic acids or disulfide bonds
(Janssen-Heininger et al., 2008). These
modifications can affect cell signaling.
For example, redox modification of the
reactive cysteine group of protein phos-
phatases reduces their function, which
can enhance kinase signaling cascades.
Using mice engineered to lack Rieske
iron sulfur protein (RISP), a component
of complex III of the respiratory chain,
specifically in T cells, Sena et al. now
show that an increase in mitochondrial
respiration is required during the
antigen-specific activation of T cells and
the subsequent increase in interleukin-2
(IL-2) expression (Sena et al., 2013).
Because exogenous replacement of
H2O2 restores Il2 expression, they sug-
gest that mitochondrial ROS, rather than
the ATP generated from oxidative phos-
phorylation, is the key component of this
signaling pathway and acts as a redox
signal that feeds back on the T cell
signal-transduction pathways to activate
IL-2 expression. The authors tie the
calcium signal, previously implicated in
increasing mitochondrial TCA-cycle
activity, to the increase in mitochondrial
respiration that generates the ROS. InImmunity 38,turn, the ROS then appear to contribute
to enhanced nuclear localization of the
transcription factor NFAT in order to in-
crease expression of Il2 and other genes
associated with T cell activation. Because
calcineurin, which activates NFAT nuclear
localization through dephosphorylation,
is itself dependent on Ca2+ for activation,
these findings identify mitochondrial
ROS as an elegant amplifier of Ca2+-
dependent steps in T cell activation
(Figure 1).
Sena et al. suggest that respiratory
complex III produces the mitochondrial
ROS signal. However, loss of RISP from
complex III also reduces respiration,
lowers mitochondrial membrane poten-
tial, and decreases mitochondrial calcium
uptake. Thus, it is possible that other
mitochondrial sources of ROS might
contribute to T cell activation. A recent
study in Cell Reports came to similar
conclusions about the role of mitochon-
drial ROS in T cell activation, but another
enzyme, mitochondrial glycerol-3-phos-
phate dehydrogenase (GPD2) was pro-
posed as the source of ROS (Kaminski
et al., 2012). These authors found that
during T cell activation, glycolysis is
diverted to produce excess glycerol-3-
phosphate, which is imported into mito-
chondria for use in lipid biosynthesis.
GPD2, located in proximity to the ETC
on the mitochondrial inner membrane,
oxidizes glycerol-3-phosphate to dihy-
droxyacetone phosphate in a flavin
adenine dinucleotide (FAD)-dependent
reaction that funnels electrons into the
coenzyme Q pool within the inner mem-
brane. Although GPD2 can probably pro-
duce ROS itself, it can also enhance the
reduction state of the coenzyme Q pool
and thus lead to ROS production at other
sites within the ETC. siRNA-mediatedFebruary 21, 2013 ª2013 Elsevier Inc. 201
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Figure 1. Pathways Involved in Mitochondrial ROS Production after T Cell Activation
TCR stimulation leads to Ca2+ release from endoplasmic reticulum stores, where it is taken up by mito-
chondria and stimulates the activity of TCA-cycle enzymes and flux through the ETC. More O2
,- is
produced as mitochondrial respiration rises to meet the metabolic demand of the cell. Sena et al.
(2013) proposemitochondrial complex III as the source of ROS. TCR stimulation also leads to upregulation
of the GLUT1 glucose transporter and glycolytic enzymes. Glycolysis in activated T cells shifts toward
production of glycerol-3 phosphate (G3P), which is taken up into mitochondria and converted to dihy-
droxyacetone phosphate (DHAP) by mitochondrial G3P dehydrogenase (GPD2) in a process that can
generate O2
,- (Kaminski et al., 2012). O2
,- produced in the mitochondria is converted to H2O2 in the mito-
chondrial matrix by MnSOD, where it can diffuse into the cytoplasm and affect signaling pathways,
including that of NFAT, which upregulates Il2 transcription. Enzymes identified by Sena et al. and Kaminski
et al. as sources of ROS are identified in red. Blue arrows denote electron flow.
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Previewsdepletion of GPD2 inhibited production of
mitochondrial ROS during T cell activation
and reduced IL-2 production. Because
GPD2 is not an essential component of
the mitochondrial ETC, these results
strengthen the evidence that ROS pro-
duction, rather than simply mitochondrial
respiration, plays a role in T cell activation.
However, because neither study tested
whether adding back ROS restored later
events such as T cell proliferation, this
remains an open question.
More studies are needed for identifying
the molecular target(s) for ROS produced
during T cell activation. Although activa-
tion of NF-kB and mitogen-activated202 Immunity 38, February 21, 2013 ª2013 Eprotein kinase can be blocked by ROS
inhibitors, the evidence from Sena et al.
points to transcription factor NFAT as
a major target. In future work, it will be
particularly important to determine the
exact proteins, and ideally the cysteine
residues, that are modified by mitochon-
drial ROS and confirm that they are linked
to the signaling process by, for example,
replacement of the putative redox sensi-
tive cysteine residues with redox-inactive
versions. Identification of target proteins
will require the approaches of redox pro-
teomics (Chouchani et al., 2011).
The issue of what role mitochondrial
ROS play in T cell responses in the intactlsevier Inc.immune system also remains unresolved.
Although Sena et al. observed reduced
T cell proliferation and blunted responses
in a mouse model of asthma with T-cell-
specific RISP-deficient mice, some of
these findings could stem from the more
global defects inmitochondrial respiration
in these cells. One might predict from
these studies that inhibitors of mitochon-
drial or general ROS might suppress
T cell responses. However, little evidence
has emerged to suggest that this is the
case. Mitochondria-targeted antioxidants
can also suppress cytokine production by
innate immune cells triggered by toll-like
receptors, perhaps through a similar
mechanism as outlined in these studies
(Bulua et al., 2011). Together, these
recent findings indicate that signaling by
mitochondrial ROSmight beawidespread
and important mode of modulating the
activity of the immune system.REFERENCES
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